spacer
home > ict > spring 2017 > word for word
PUBLICATIONS
International Clinical Trials

Word for Word

Juan Julián León: It’s true that globalisation is having an immediate impact on pharma, both in corporate and institutional environments. With each passing day, regulations become more global and this, in turn, directly affects the translation sector. Indeed, demand for translation services has not only risen, but these services have also had to evolve to adapt to this changing environment.

The translation sector now faces new obstacles, one of which is the need to continually attract and retain talent. Pharma translation is a much specialised field, and requires highly trained and experienced professionals. Translation companies expend great efforts maintaining and developing specialised multidisciplinary teams in this industry, including native translators for many languages, linguists, experts in medical and pharma regulations and terminology, reviewers, editors, layout designers, developers and so forth.

Another hurdle we face is the need to adapt to constantly changing terminology. The emergence of new illnesses, compositions and medicines demands that we continuously update our knowledge.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Juan Julián León is a renowned expert in the translation, localisation and intellectual property industry. Of particular note is his participation in the creation and expansion of one of the industry's top firms, SeproTec Multilingual Solutions, now present in 11 countries with over 400 employees. Today, Juan Julián continues in his role as Chief Executive Officer of the company and has participated in operations as crucial as its international expansion, the acquisition of the Polish firm Lidolang and the creation of SHIP Global IP, an innovative initiative in the intellectual property industry.
spacer
Juan Julián León
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Wickham Laboratories will be on Stand 8 at the 24th Annual Pharmig Conference in the Nottingham Belfry Hotel, November 16th & 17th


More info >>

White Papers

Biosimilars In Emerging Markets: Is It A Level Playing Field?

PRA Health Sciences (PRA)

Governments, healthcare payers, and social and health reforms, combined with the increased incidence of conditions such as cancer and diabetes are paving the way for increased uptake of biologic medicines in emerging markets. However, expensive biologic medicines can be prohibitive to many patients, creating a high level of unmet clinical need. At its best, the global expansion of biosimilars can mean a robust and steady supply of existing and new drugs reaching far-flung patient populations, but localized biosimilar drug developments, especially in China and India, combined with a lack of robust pharmacovigilance systems, threaten to derail the industry by putting patient health at risk.
More info >>

 
Industry Events

12th annual Cold Chain Distribution Conference and Exhibition

13-14 December 2017, Copthorne Tara Hotel, London, UK

Responding to the evolution within the industry, SMi is proud to announce the return of its leading 12th annual Cold Chain Distribution event. Returning to London in December, this year's event will remain at the forefront of innovation
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement